QALSODY (tofersen) injection
QALSODY is a prescription medicine used to treat amyotrophic lateral sclerosis (ALS). FDA approved tofersen (brand name QALSODY) is not (yet) registered or available in India but on request Indian patient can buy QALSODY at the lowest price.
Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Indian Patient Enquiry under NPP.
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
QALSODY (tofersen) injection
Tofersen is indicated to treat people with amyotrophic lateral sclerosis (ALS) associated with a mutation in the superoxide dismutase 1 (SOD1) gene (SOD1-ALS).
QALSODY is an antisense oligonucleotide indicated for the treatment of amyotrophic lateral sclerosis (ALS) in adults who have a mutation in the superoxide dismutase 1 (SOD1) gene. This indication is approved under accelerated approval based on reduction in plasma neurofilament light chain observed in patients treated with QALSODY.
Tofersen, sold under the brand name Qalsody, is a medication used for the treatment of amyotrophic lateral sclerosis (ALS). Tofersen is an antisense oligonucleotide that targets the production of superoxide dismutase 1, an enzyme whose mutant form is commonly associated with amyotrophic lateral sclerosis. Tofersen was approved for medical use in the United States in April 2023, and in the European Union in May 2024. The US Food and Drug Administration (FDA) considers it to be a first-in-class medication.
The most common side effects include fatigue, arthralgia (joint pain), increased cerebrospinal (brain and spinal cord) fluid white blood cells, and myalgia (muscle pain).
QALSODY (tofersen) injection, for intrathecal use Initial U.S. Approval: 2023
—————-
Current Indication: Treat amyotrophic lateral sclerosis (ALS)
—————-
Marketed By: Biogen a
—————-
Approval Date: : 2023
—————-
Active ingredients: tofersen
—————-
Injection: 100 mg/15 mL (6.7 mg/mL) solution in a single-dose vial
Find Reference Updates
- For QALSODY (tofersen) injection And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions.
- FDA Grants Accelerated Approval for QALSODY™ (tofersen) for SOD1-ALS, a Major Scientific Advancement as the First Treatment to Target a Genetic Cause of ALS
- FDA approves treatment of amyotrophic lateral sclerosis associated with a mutation in the SOD1 gene
- FDA approves QALSODY™ (tofersen) as the first treatment targeting a genetic cause of ALS
For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here
Alleviare Life Sciences
About Us
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.
Alleviare India is certified pharmaceutical facilitator / supplier /importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “ QALSODY (tofersen) injection ”. Confirmation of the order for QALSODY (tofersen) injection will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.
Request to call @ +91-9289711087 / 9289711088 or WhatsApp @ +91-9289711087 / 9289711088 or mail @ – info@alleviareindia.com + for QALSODY availability and prices in India. We guarantee the authenticity and quality of our products and offer worldwide delivery according to the buyer’s specifications.
Get Access to FDA approved tofersen (brand name QALSODY) India.
We have delivered medicines to following cities in India – Ahmedabad, Bangalore, Surat, Kolkata, Pune, Indore, Nagpur, Agra, Kanpur, Patna, Coimbatore, Kochi, Delhi, Gurugram, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Bhopal, Mumbai, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Agartala, Lucknow, Dehradun, Gairsain. Aizawal, Aurangabad, Barshi, Cachar, Dibrugarh, Karungapally, Kollam, Meghalaya, Mizoram, Sikkim, Pondichery, Punjab, Tripura, New Delhi, Agra, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad.
QALSODY Sourcing & Delivery
Alleviare India specializes in sourcing and supplying QALSODY, a cancer treatment medicine, from around the world. They offer worldwide access to the best available treatment options. Alleviare India can dispense any valid prescription quickly and helps connect patients with potential distributors, wholesalers, suppliers, and dealers of QALSODY in India.
How much does QALSODY cost in the India?
Kindly reach out to us for QALSODY (tofersen) injection price and availability confirmation. The price of the medicines is the cost set by the manufacturer. In addition, Named Patient support fee, shipping costs and any local tax (if applicable) will apply.
What documents are required to import QALSODY to India?
To import tofersen – QALSODY, patients or government hospitals can place an order on behalf of the patients. The following documentation is required for the import process:
- Valid prescription from a qualified doctor.
- Patients’ diagnostic reports.
- Patients’ ID proof issued by the Government of India.
The order will be confirmed only after the receipt of the following:
- Valid prescription from the doctor.
- Import permit, if applicable.
Please ensure that all the necessary documentation is provided to confirm the order.
Is QALSODY available in India?
QALSODY – tofersen is a prescription medication, which means it legally requires a medical prescription to be dispensed. Alleviare India assists in importing cancer medicines through the named patient supply (NPS) program. They provide information on the availability and prices of medications in various cities in India, such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, and Pune. Alleviare ensures 100% transparency and helps find genuine and reliable sources from Canada, Europe, USA, and Australia. They can facilitate the supply of QALSODY (prescription medicines) to locations worldwide, including India, while ensuring compliance with legal requirements.
Request to call @ +91-9289711087 / 9289711088 or WhatsApp @ +91-9289711087 / 9289711088 or mail @ – info@alleviareindia.com + for QALSODY availability and prices in India. We guarantee the authenticity and quality of our products and offer worldwide delivery according to the buyer’s specifications.
Is tofersen available in India?
Yes, FDA approved tofersen (brand name QALSODY) is not (yet) registered or available in India but on request Indian patient can buy QALSODY at the lowest price. Alleviare will help patient / doctor to get in India.
How overseas patient can get access?
ALS serves as a facilitator, supplier & exporter in India assisting patients, doctors, and hospitals in importing the prescription medicine brand QALSODY (tofersen) injection . The import process requires a valid prescription and an Import License in the Patient’s Name.
